MTOR and hepatocellular carcinoma: Therefore, it can be deduced from these in vitro studies as summarized in Table 1 that VD acts as an anti-tumor agent in HCC, and it could regulate tumor growth/progression through cell cycle modulation and mTOR inhibition.